• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心与肝的相互作用。

Interactions of the heart and the liver.

机构信息

Centre of Functional and Diagnostic Imaging and Research, Department of Clinical Physiology and Nuclear Medicine, Hvidovre Hospital, The Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Eur Heart J. 2013 Sep;34(36):2804-11. doi: 10.1093/eurheartj/eht246. Epub 2013 Jul 12.

DOI:10.1093/eurheartj/eht246
PMID:23853073
Abstract

There is a mutual interaction between the function of the heart and the liver and a broad spectrum of acute and chronic entities that affect both the heart and the liver. These can be classified into heart diseases affecting the liver, liver diseases affecting the heart, and conditions affecting the heart and the liver at the same time. In chronic and acute cardiac hepatopathy, owing to cardiac failure, a combination of reduced arterial perfusion and passive congestion leads to cardiac cirrhosis and cardiogenic hypoxic hepatitis. These conditions may impair the liver function and treatment should be directed towards the primary heart disease and seek to secure perfusion of vital organs. In patients with advanced cirrhosis, physical and/or pharmacological stress may reveal a reduced cardiac performance with systolic and diastolic dysfunction and electrophysical abnormalities termed cirrhotic cardiomyopathy. Electrophysiological abnormalities include prolonged QT interval, chronotropic incompetance, and electromechanical uncoupling. No specific therapy can be recommended, but it should be supportive and directed against the heart failure. Numerous conditions affect both the heart and the liver such as infections, inflammatory and systemic diseases, and chronic alcoholism. The risk and prevalence of coronary artery disease are increasing in cirrhotic patients and since the perioperative mortality is high, a careful cardiac evaluation of such patients is required prior to orthotopic liver transplantation.

摘要

心脏和肝脏的功能之间存在相互作用,并且有广泛的急性和慢性实体影响心脏和肝脏。这些可以分为影响肝脏的心脏病、影响心脏的肝病以及同时影响心脏和肝脏的情况。在慢性和急性心脏肝病中,由于心力衰竭,动脉灌注减少和被动充血的组合导致心脏肝硬化和心源性缺氧性肝炎。这些情况可能会损害肝功能,治疗应针对主要的心脏病,并设法确保重要器官的灌注。在晚期肝硬化患者中,身体和/或药理学应激可能会导致收缩和舒张功能障碍以及称为肝硬化心肌病的电生理异常的心脏性能降低。电生理异常包括 QT 间期延长、变时性无能和机电分离。目前还没有推荐特定的治疗方法,但应支持和针对心力衰竭进行治疗。许多情况会同时影响心脏和肝脏,如感染、炎症和全身性疾病以及慢性酒精中毒。肝硬化患者的冠心病风险和患病率正在增加,由于围手术期死亡率较高,因此在进行原位肝移植之前,需要对这些患者进行仔细的心脏评估。

相似文献

1
Interactions of the heart and the liver.心与肝的相互作用。
Eur Heart J. 2013 Sep;34(36):2804-11. doi: 10.1093/eurheartj/eht246. Epub 2013 Jul 12.
2
The heart and the liver.心脏和肝脏。
Expert Rev Gastroenterol Hepatol. 2009 Feb;3(1):51-64. doi: 10.1586/17474124.3.1.51.
3
Heart and liver disease in 32 patients undergoing biopsy of both organs, with implications for heart or liver transplantation.32例接受心脏和肝脏活检患者的心脏与肝脏疾病,及其对心脏或肝脏移植的影响。
Mayo Clin Proc. 2004 Apr;79(4):492-501. doi: 10.4065/79.4.492.
4
Heart diseases affecting the liver and liver diseases affecting the heart.影响肝脏的心脏病和影响心脏的肝脏疾病。
Am Heart J. 2000 Jul;140(1):111-20. doi: 10.1067/mhj.2000.107177.
5
The heart in liver transplantation.肝移植中心脏。
J Hepatol. 2011 Apr;54(4):810-22. doi: 10.1016/j.jhep.2010.11.003. Epub 2010 Nov 11.
6
Therapy insight: Cirrhotic cardiomyopathy.治疗洞察:肝硬化性心肌病。
Nat Clin Pract Gastroenterol Hepatol. 2006 Jun;3(6):329-37. doi: 10.1038/ncpgasthep0498.
7
Relationship between Heart Disease and Liver Disease: A Two-Way Street.心脏病与肝病的关系:双向影响。
Cells. 2020 Feb 28;9(3):567. doi: 10.3390/cells9030567.
8
Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome.肝移植前的血流动力学评估:对门静脉高压综合征的见解
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S323-9. doi: 10.1097/MCG.0b013e318157188e.
9
New insights into cirrhotic cardiomyopathy.肝硬化性心肌病的新见解。
Int J Cardiol. 2013 Aug 20;167(4):1101-8. doi: 10.1016/j.ijcard.2012.09.089. Epub 2012 Oct 4.
10
Hepato-cardiac disorders.肝心疾病
World J Hepatol. 2014 Jan 27;6(1):41-54. doi: 10.4254/wjh.v6.i1.41.

引用本文的文献

1
Model for End-Stage Liver Disease Excluding INR Is Associated with Poor Prognosis in Elderly Patients with Decompensated Heart Failure.排除国际标准化比值的终末期肝病模型与老年失代偿性心力衰竭患者的不良预后相关。
Biomedicines. 2025 Aug 18;13(8):2000. doi: 10.3390/biomedicines13082000.
2
FIB-4, a surrogate marker of liver fibrosis, predicts mortality and adverse events after acute myocardial ınfarction.FIB-4是肝纤维化的替代标志物,可预测急性心肌梗死后的死亡率和不良事件。
Intern Emerg Med. 2025 Aug 19. doi: 10.1007/s11739-025-04094-z.
3
Early Atropine Protocol Enhances Dobutamine Stress Echocardiography in End-Stage Liver Disease: A Practical Cardiac Risk Stratification Tool Before Liver Transplantation.
早期阿托品方案增强终末期肝病患者多巴酚丁胺负荷超声心动图检查效果:一种肝移植前实用的心脏风险分层工具
Ann Transplant. 2025 Aug 12;30:e950166. doi: 10.12659/AOT.950166.
4
Metronidazole induces genotoxicity, hepato- and nephrotoxicity by triggering DNA fragmentation in Swiss albino mice (Balb/c).甲硝唑通过引发瑞士白化小鼠(Balb/c)的DNA片段化而诱导遗传毒性、肝毒性和肾毒性。
Sci Rep. 2025 Jul 18;15(1):26187. doi: 10.1038/s41598-025-12230-0.
5
Effect of vitamin D and location of asprosin, spexin and meteorin-like antibodies in the liver of rats with isoproterenol-induced myocardial infarction.维生素D以及抑胃肽、信号肽和类流星蛋白抗体在异丙肾上腺素诱导的大鼠心肌梗死肝脏中的定位影响。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 28. doi: 10.1007/s00210-025-04409-z.
6
Identification of Plasma Lipidomic Signatures Associated with Coronary Plaque Vulnerability.与冠状动脉斑块易损性相关的血浆脂质组学特征的鉴定
J Cardiovasc Transl Res. 2025 Jun 20. doi: 10.1007/s12265-025-10646-7.
7
Understanding acute kidney injury in cirrhosis: Current perspective.肝硬化患者急性肾损伤的认识:当前观点
World J Hepatol. 2025 May 27;17(5):104724. doi: 10.4254/wjh.v17.i5.104724.
8
Electrocardiogram-based diagnosis of liver diseases: an externally validated and explainable machine learning approach.基于心电图的肝脏疾病诊断:一种经过外部验证且可解释的机器学习方法。
EClinicalMedicine. 2025 May 20;84:103242. doi: 10.1016/j.eclinm.2025.103242. eCollection 2025 Jun.
9
Integrated plasma and vegetation proteomic characterization of infective endocarditis for early diagnosis and treatment.感染性心内膜炎的血浆和植被蛋白质组综合表征用于早期诊断和治疗。
Nat Commun. 2025 May 30;16(1):5052. doi: 10.1038/s41467-025-60184-8.
10
Cirrhosis Promotes Cardiac Fibrosis Development by Inhibiting Notch1 in Cardiac Fibroblasts.肝硬化通过抑制心脏成纤维细胞中的Notch1促进心脏纤维化发展。
JACC Basic Transl Sci. 2025 May;10(5):612-631. doi: 10.1016/j.jacbts.2024.11.015. Epub 2025 Feb 26.